HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Salman M Hyder Selected Research

Progestins (Progestagens)

1/2013The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
8/2012Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
3/2012Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model.
8/2011Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
9/2010Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
9/2010Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
9/2010Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells.
1/2010Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
9/2009Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
5/2008Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Salman M Hyder Research Topics

Disease

31Breast Neoplasms (Breast Cancer)
01/2015 - 07/2002
29Neoplasms (Cancer)
01/2015 - 07/2002
3Breast Diseases (Breast Disease)
08/2012 - 10/2007
2Neoplasm Metastasis (Metastasis)
09/2010 - 02/2005
1Hyperplasia
08/2011

Drug/Important Bio-Agent (IBA)

21Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 07/2002
19Estrogens (Estrogen)FDA Link
01/2015 - 04/2004
15Progestins (Progestagens)IBA
01/2013 - 02/2005
11Progesterone CongenersIBA
01/2015 - 02/2005
10HormonesIBA
10/2014 - 09/2006
9Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
01/2015 - 10/2007
8Progesterone Receptors (Progesterone Receptor)IBA
05/2013 - 02/2005
79,10-Dimethyl-1,2-benzanthracene (DMBA)IBA
01/2013 - 07/2006
62,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA
04/2011 - 10/2007
5Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2015 - 05/2008
5fulvestrant (Faslodex)FDA Link
09/2009 - 07/2002
4Messenger RNA (mRNA)IBA
10/2014 - 02/2005
4ApigeninIBA
01/2013 - 09/2010
4ProgesteroneFDA LinkGeneric
09/2010 - 07/2002
3Mifepristone (RU 486)FDA Link
09/2010 - 07/2006
3Estradiol (Estrace)FDA LinkGeneric
09/2010 - 04/2004
3anthraceneIBA
01/2010 - 07/2006
3Thrombospondin 1IBA
09/2009 - 04/2004
2lanosterol synthaseIBA
10/2014 - 07/2014
2CholesterolIBA
10/2014 - 07/2014
2Ro 48-8071IBA
07/2014 - 04/2011
2Norethindrone (Norethisterone)FDA LinkGeneric
05/2013 - 09/2010
2CurcuminIBA
01/2010 - 05/2008
2Estrogen ReceptorsIBA
09/2009 - 04/2004
2Conditioned Culture MediaIBA
09/2009 - 08/2005
2Angiogenesis InhibitorsIBA
10/2007 - 07/2006
2TamoxifenFDA LinkGeneric
12/2005 - 03/2004
2progesterone receptor BIBA
12/2005 - 03/2004
1Aldehyde DehydrogenaseIBA
01/2015
1LuteolinIBA
01/2015
1AndrogensIBA
10/2014
1EnzymesIBA
10/2014
1fluvastatinFDA Link
07/2014
1lissamine rhodamine B (sulforhodamine B)IBA
07/2014
1Simvastatin (Zocor)FDA LinkGeneric
07/2014
1tranilast (N 5')IBA
05/2013
13- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazole (YC 1)IBA
01/2013
1Phytoestrogens (Phytoestrogen)IBA
01/2013
1RANK LigandIBA
08/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2012
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2012
1Complement System Proteins (Complement)IBA
12/2011
1Adenosine Triphosphate (ATP)IBA
12/2011
1Mitochondrial Proteins (Mitochondrial Protein)IBA
12/2011
1Small Interfering RNA (siRNA)IBA
12/2011
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
08/2011
1Staphylococcal Protein A (A, Protein)IBA
01/2011
1PhospholipidsIBA
01/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2010
1flavoneIBA
09/2010
1Norgestrel (DL-Norgestrel)FDA LinkGeneric
09/2010
1Cysteine (L-Cysteine)FDA Link
03/2009
1matrigelIBA
10/2007
1Estrogen Receptor alphaIBA
10/2007
1Estrogen Receptor betaIBA
10/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2005
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2005
1Phosphotransferases (Kinase)IBA
02/2005
1Transcription Factors (Transcription Factor)IBA
02/2005
1Estrogen Receptor Modulators (Antiestrogen)IBA
07/2002

Therapy/Procedure

11Heterologous Transplantation (Xenotransplantation)
01/2015 - 10/2007
6Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2015 - 08/2005
3Contraception (Birth Control)
09/2010 - 08/2005
2Therapeutics
12/2011 - 10/2007
1Aftercare (After-Treatment)
01/2011
1Injections
09/2010
1Estrogen Replacement Therapy
10/2007